Comparative Pharmacology
Head-to-head clinical analysis: MINIRIN versus STIMATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MINIRIN versus STIMATE.
MINIRIN vs STIMATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Desmopressin is a synthetic analog of antidiuretic hormone (ADH) that increases water reabsorption in the renal collecting ducts by binding to V2 receptors, leading to increased aquaporin-2 expression and reduced urine output.
Desmopressin acetate is a synthetic analog of the natural pituitary hormone 8-arginine vasopressin (ADH). It acts as a V2 receptor agonist in the renal collecting ducts, increasing water permeability and promoting water reabsorption, thereby reducing urine output. It also increases plasma levels of von Willebrand factor and factor VIII via V2 receptor stimulation on endothelial cells.
Adults: 1-2 sprays intranasally (10 mcg each) once daily; for diabetes insipidus, 1-2 sprays once or twice daily. Oral: 0.1-0.2 mg three times daily.
Intranasal: 1 spray (1.5 mg) into one nostril, 1 hour prior to voiding or on awakening for bedwetting; maximum 2 sprays per day.
None Documented
None Documented
Clinical Note
moderateNorgestimate + Atazanavir
"The serum concentration of Atazanavir can be increased when it is combined with Norgestimate."
Clinical Note
moderateNorgestimate + Fosamprenavir
"The serum concentration of the active metabolites of Fosamprenavir can be reduced when Fosamprenavir is used in combination with Norgestimate resulting in a loss in efficacy."
Clinical Note
moderateNorgestimate + Cobicistat
"The serum concentration of Cobicistat can be increased when it is combined with Norgestimate."
Clinical Note
moderateTerminal elimination half-life: 2–3 hours (intravenous, subcutaneous); 3–5 hours (oral). Clinical context: Short half-life necessitates frequent dosing; duration of antidiuretic effect may outlast plasma levels due to receptor binding.
Terminal elimination half-life is approximately 3-4 hours in healthy adults, but may be prolonged in patients with renal impairment or in older adults.
Renal (primarily as unchanged drug via glomerular filtration and tubular secretion; ~65% of an intravenous dose excreted unchanged in urine within 24 hours); fecal (~5–10% of an oral dose); minimal biliary elimination.
Desmopressin is primarily excreted renally, with approximately 60-70% of the dose recovered unchanged in urine within 24 hours. The remaining fraction is metabolized hepatically and eliminated via feces.
Category C
Category C
Antidiuretic Hormone Analog
Antidiuretic Hormone Analog
Norgestimate + Boceprevir
"The serum concentration of Boceprevir can be increased when it is combined with Norgestimate."